Boji Medical Technology Co.,Ltd. (SHE:300404)

Market Cap	3.87B +3.7%
Revenue (ttm)	770.19M +2.3%
Net Income	7.41M -83.4%
EPS	0.02 -83.5%
Shares Out	383.20M
PE Ratio	522.10
Forward PE	n/a
Dividend	0.01 (0.12%)
Ex-Dividend Date	Jul 15, 2025

Volume	7,902,300
Average Volume	11,240,731
Open	10.34
Previous Close	10.30
Day's Range	10.03 - 10.34
52-Week Range	7.83 - 13.15
Beta	0.28
RSI	49.24
Earnings Date	Apr 25, 2026

About Boji Medical Technology

Boji Medical Technology Co.,Ltd. provides professional contract research services for research and development, and production of drugs and medical devices to pharmaceutical enterprises in China and internationally. It offers pre-clinical research, clinical research, and other consulting services. The company also provides clinical drug production, pilot test scale-up, process verification batch production, and drug registration and approval services. In addition, it engages in the screening, evaluation, verification, and trading of technologic...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1998
• Employees: 1,205
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300404

Financial Performance

In 2024, Boji Medical Technology's revenue was 742.02 million, an increase of 33.50% compared to the previous year's 555.83 million. Earnings were 28.78 million, an increase of 18.23%.